Association of anti-CCP positivity with serum ferritin and DAS-28

Rheumatology International

Volumn 30, Issue 2, 2009, Pages 223-227

  Önder, Burcu ^a   Kurtaran, Aydan ^a   Kimyon, Songül ^a   Selçuk, Barin ^a   Akyüz, Müfit ^a  

^a ANKARA PHYSICAL MEDICINE AND REHABILITATION TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Anti CCP antibodies; Disease activity; Ferritin; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FERRITIN; HEMOGLOBIN; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; ANEMIA; ARTICLE; BLOOD CELL COUNT; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PAIN ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COHORT STUDIES; FEMALE; FERRITINS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 71349083614     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0941-4     Document Type: Article

References (38)

1. DM Lee ME Weinblatt 2001 Rheumatoid arthritis Lancet 358 903 911 10.1016/S0140-6736(01)06075-5 1:CAS:528:DC%2BD3MXmvVKmtr8%3D 11567728 (Pubitemid 32900579)
2. MC Hochberg 1993 Predicting the prognosis of patients with rheumatoid arthritis: is there a crystal ball? J Rheumatol 20 1265 1267 1:STN:280:DyaK2c%2Fks1yguw%3D%3D 8230003
3. C Turesson MW O'Fallon CS Crowson SE Gabriel EL Matteson 2002 Occurrence of extra-articular disease manifestation is associated with excess mortality in a community-based cohort of patients with rheumatoid arthritis J Rheumatol 29 62 67 11824973
4. T Dörner K Egerer E Feist GR Burmester 2004 Rheumatoid factor revisited Curr Opin Rheumatol 16 246 253 10.1097/00002281-200405000-00013 15103252 (Pubitemid 38530493)
5. RL Nienhuis E Mandema 1964 A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor Ann Rheum Dis 23 302 305 10.1136/ard.23.4.302 1:STN:280:DyaF2c7js1Siug%3D%3D 14178016
6. BJ Young RK Mallya RD Leslie CJ Clark TJ Hamblin 1979 Anti-keratinantibodies in rheumatoid arthritis Br Med J 2 97 99 10.1136/bmj.2.6182.97 1:CAS:528:DyaL3cXhvF2msA%3D%3D 111762
7. ER Vossenaar N Despre's E Lapointe A van der Heijden M Lora T Senshu, et al. 2004 Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin Arthritis Res Ther 6 R142 R150 10.1186/ar1149 1:CAS:528: DC%2BD2cXktValtLw%3D 15059278
8. ER Vossenaar TR Radstake A van der Heijden MA van Mansum C Dieteren DJ de Rooij, et al. 2004 Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages Ann Rheum Dis 63 373 381 10.1136/ard.2003.012211 1:CAS:528:DC%2BD2cXjs1ahs74%3D 15020330 (Pubitemid 38453302)
9. ER Vossenaar AJ Zendman WJ van Venrooij GJ Pruijn 2003 PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease Bioessays 25 1106 1118 10.1002/bies.10357 1:CAS:528:DC%2BD3sXpsFyrsb0%3D 14579251 (Pubitemid 37411770)
10. GA Schellekens BA de Jong FH van den Hoogen LB van de Putte WJ van Venrooij 1998 Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J Clin Invest 101 273 281 10.1172/JCI1316 1:CAS:528:DyaK1cXjtFSjsg%3D%3D 9421490
11. GA Schellekens H Visser BA de Jong FH van den Hoogen JM Hazes FC Breedveld, et al. 2000 The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum 43 155 163 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3 1:CAS:528:DC%2BD3cXns1ygtg%3D%3D 10643712 (Pubitemid 30368225)
12. AJW Zendman WJ van Venrooij GJM Pruijn 2006 Use and significance of anti-CCP autoantibodies in rheumatoid arhritis Rheumatology 45 20 25 10.1093/rheumatology/kei111 1:STN:280:DC%2BD2MnnsVymsA%3D%3D 16188946 (Pubitemid 43033869)
13. A Ates Y Karaaslan S Aksaray 2006 Predictive value of autoantibodies to cyclic citrullinated peptide in patients with early arthritis Clin Rheumatol 25 743 745 10.1007/s10067-005-0039-7 (Pubitemid 44111323)
14. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper LA Healey SR Kaplan MH Liang HS Luthra, et al. 1998 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302
15. N Bizzaro G Mazzanti E Tonutti D Villalta R Tozzoli 2001 Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis Clin Chem 47 6 1089 1093 1:CAS:528:DC%2BD3MXktFels78%3D 11375296
16. K Nishimura D Sugiyama Y Kogata G Tsuji T Nakazawa S Kawano K Saigo A Morinobu M Koshiba KM Kuntz I Kamae S Kumagai 2007 Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis Ann Intern Med 146 11 797 808 17548411
17. I Alexiou A Germenis A Ziogas K Theodoridou LI Sakkas 2007 Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis BMC Musculoskelet Disord 8 37 10.1186/1471-2474-8-37 17448247 (Pubitemid 46788700)
18. AM Nieto-Colonia WS Santos SP Keusseyan W Caldana AR Fernandes LE Andrade 2008 Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis Braz J Med Biol Res 41 3 188 192 10.1590/S0100-879X2008005000005 1:CAS:528:DC%2BD1cXks1Slurc%3D 18235966
19. O Vittecoq B Incaurgarat F Jouen-Beades J Legoedec O Letourneur D Rolland G Gervasi JF Ménard A Gayet P Fardellone A Daragon M Jolivet X le Loët F Tron 2004 Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis Clin Exp Immunol 135 1 173 180 10.1111/j.1365-2249.2004.02341.x 1:CAS:528:DC%2BD2cXnslGjtA%3D%3D 14678280 (Pubitemid 38067943)
20. E Berglin L Padyukov U Sundin G Hallmans H Stenlund WJ Van Venrooij L Klareskog SR Dahlqvist 2004 A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis Arthritis Res Ther 6 4 R303 R308 10.1186/ar1187 1:CAS:528:DC%2BD2cXkvVOhur4%3D 15225365
21. M Bukhari W Thomson H Naseem D Bunn A Silman D Symmons A Barton 2007 The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register Arthritis Rheum 56 9 2929 2935 10.1002/art.22868 1:STN:280:DC%2BD2srnt1Cqtw%3D%3D 17763407 (Pubitemid 47502739)
22. EJ Kroot BA de Jong MA van Leeuwen H Swinkels FH van den Hoogen M van't Hof LB van de Putte MH van Rijswijk WJ van Venrooij PL van Riel 2000 The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis Rheum 43 8 1831 1835 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6 1:CAS:528:DC%2BD3cXmtFKju7w%3D 10943873 (Pubitemid 30640938)
23. S Agrawal R Misra A Aggarwal 2007 Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA Clin Rheumatol 26 2 201 204 10.1007/s10067-006-0275-5 16572283 (Pubitemid 46020244)
24. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines 2002 Guidelines for the management of rheumatoid arthritis: 2002 update Arthritis Rheum 46 328 10.1002/art.10148 (Pubitemid 34136570)
25. JF Fries PW Spitz DY Young 1982 The dimensions of health outcomes: the health assessment questionnaire, disability, pain scales J Rheumatol 9 789 1:STN:280:DyaL3s%2FosFGqtw%3D%3D 7175852
26. JF Fries PW Spitz RG Kraines, et al. 1980 Measurement of patient outcome in arthritis Arthritis Rheum 23 137 10.1002/art.1780230202 1:STN:280: DyaL3c7ltlGlsQ%3D%3D 7362664 (Pubitemid 10164318)
27. SK Lane JW Gravel Jr 2002 Clinical utility of common serum rheumatologic tests Am Fam Physician 65 1073 11925083
28. F Donald MM Ward 1998 Evaluative laboratory testing practices of United States rheumatologists Arthritis Rheum 41 725 10.1002/1529-0131(199804)41: 4<725::AID-ART21>3.0.CO;2-Z 1:STN:280:DyaK1c3gvFymsQ%3D%3D 9550483 (Pubitemid 28214992)
29. J Listing R Rau B Muller Berlin Collaborating Rheumatological Study Group, et al. 2000 HLA-DRB1 genes, rheumatoid factor, elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis J Rheumatol 27 2100 1:STN:280:DC%2BD3cvkt1alug%3D%3D 10990219
30. F Wolfe SM Kleinheksel MA Cathey, et al. 1988 The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis J Rheumatol 15 1480 1:STN:280:DyaL1M%2FotFamsQ%3D%3D 3204597
31. B Bruce JF Fries 2003 The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, documentation J Rheumatol 30 167 12508408
32. MLL Prevoo MA van't Hof HH Kuper LBA van de Putte, et al. 1995 Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 3 44 10.1002/art.1780380107
33. NG Papadopoulos GZ Tsiaousis A Pavlitou-Tsiontsi A Giannakou VK Galanopoulou 2008 Does the presence of anti-CCP autoantibodies and their serum levels influence the severity and activity in rheumatoid arthritis patients? Clin Rev Allergy Immunol 34 1 11 15 10.1007/s12016-007-8018-1 1:CAS:528:DC%2BD1cXkt1Kmtb0%3D 18270851
34. N Inanc E Dalkilic S Kamali E Kasapoglu-Günal Y Elbir H Direskeneli M Inanc 2007 Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis Clin Rheumatol 26 1 17 23 10.1007/s10067-006-0214-5 1:STN:280: DC%2BD2s%2FoslGlug%3D%3D 16538391 (Pubitemid 46020016)
35. M Serdaroǧlu H Cakirbay O Deǧer S Cengiz S Kul 2008 The association of anti-CCP antibodies with disease activity in rheumatoid arthritis Rheumatol Int 28 10 965 970 10.1007/s00296-008-0570-3 18418600
36. M Glasnović I Bosnjak A Vcev I Soldo E Glasnović- Horvatić S Soldo-Butković J Pavela N Mićunović 2007 Anti-citrullinated antibodies, radiological joint damages and their correlations with disease activity score (DAS28) Coll Antropol 31 1 345 348 17598422
37. EJ Fitzsimons T Houston R Munro RD Sturrock AB Speekenbrink JH Brock 2002 Erythroblast iron metabolism and serum soluble transferrin receptor values in the anemia of rheumatoid arthritis Arthritis Rheum 47 2 166 171 10.1002/art.10247 1:CAS:528:DC%2BD38Xjs1Kgtr8%3D 11954010
38. H Orbach G Zandman-Goddard H Amital V Barak Z Szekanecz G Szucs K Danko E Nagy T Csepany JF Carvalho A Doria Y Shoenfeld 2007 Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases Ann N Y Acad Sci 1109 385 400 10.1196/annals.1398.044 1:CAS:528:DC%2BD2sXhtVyjsb%2FP 17785327 (Pubitemid 47511381)